ReachMD

Episodes 1-15 of 109

• • 

    

    Hector O. Chapa, MD

    Peer

  2

  

  RestartResume

  COVID-19 Vaccines & Abnormal Mammograms: A Proposed Plan of Care

  COVID-19 Vaccines & Abnormal Mammograms: A Proposed Plan of Care

• • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Nadia N. Laack, MD

    Peer

  5

  

  RestartResume

  Advances in Proton Therapy for Pediatric Brain Tumors

  Advances in Proton Therapy for Pediatric Brain Tumors

• • 

    

    Peter Buch, MD, FACG, AGAF, FACP

    Peer

  • 

    

    Rajeev Attam, MD

    Peer

  0

  

  RestartResume

  Perspectives on Pancreatic Cysts: How to Determine Malignancy

  Perspectives on Pancreatic Cysts: How to Determine Malignancy

• • 

    

    Jacob Sands, MD

    Peer

  • 

    

    Aaron S. Mansfield, MD

    Peer

  3

  

  RestartResume

  Exploring Early-Stage Mesothelioma: What Are the Latest Treatment Approaches?

  Exploring Early-Stage Mesothelioma: What Are the Latest Treatment Approaches?

• • 

    

    Jacob Sands, MD

    Peer

  • 

    

    Aaron S. Mansfield, MD

    Peer

  3

  

  RestartResume

  A Step-by-Step Approach to Managing Mesothelioma 

  A Step-by-Step Approach to Managing Mesothelioma 

• • 

    

    Alvin F. Wells, MD, PhD

    Peer

  6

  

  RestartResume

  Elaine Can’t Miss Another Game: Managing Osteoarthritis Pain in Vulnerable Populations

  Elaine Can’t Miss Another Game: Managing Osteoarthritis Pain in Vulnerable Populations

  0.25 credits

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Paolo Balsorano, MD

    Peer

  • 

    

    Gregory J. Schears, MD

    Peer

  4

  

  RestartResume

  Comparing Complications: Centrally vs. Peripherally Inserted Central Catheters

  Comparing Complications: Centrally vs. Peripherally Inserted Central Catheters

• • 

    

    Zulma Yunt, MD

    Peer

  • 

    

    Amy L. Olson, MD, MSPH

    Peer

  • 

    

    Virginia D. Steen, MD

    Peer

  11

  

  RestartResume

  SSc-ILD: The Importance of Early Diagnosis, Patient Centered Communication and Evidence Based Treatment

  SSc-ILD: The Importance of Early Diagnosis, Patient Centered Communication and Evidence Based Treatment

  1.00 credits

• • 

    

    Robert Mocharnuk, MD

    Peer

  • 

    

    Richard S. Finn, MD

    Peer

  • 

    

    Amit Singal, MD, MS

    Peer

  10

  

  RestartResume

  Multidisciplinary Perspectives in Advanced HCC:  A Focus on Immune Checkpoint Inhibitors

  Multidisciplinary Perspectives in Advanced HCC:  A Focus on Immune Checkpoint Inhibitors

  0.75 credits

• • 

    

    Kevin Brown, MD

    Peer

  • 

    

    Kevin R. Flaherty, MD

    Peer

  • 

    

    Rebecca C. Keith, MD

    Peer

  9

  

  RestartResume

  Emerging Treatments: Diagnosis and Treatment of Chronic Fibrosing ILD with a Progressive Lung Disease Phenotype

  Emerging Treatments: Diagnosis and Treatment of Chronic Fibrosing ILD with a Progressive Lung Disease Phenotype

  1.00 credits

• • 

    

    Lynn M. Schuchter, MD

    Peer

  3

  

  RestartResume

  Keeping Melanoma Patients Safe Amid COVID-19

  Keeping Melanoma Patients Safe Amid COVID-19

• • 

    

    Bret Nelson, MD

    Peer

  1

  

  RestartResume

  What to Look for When Using Point-of-Care Ultrasound for COVID-19

  What to Look for When Using Point-of-Care Ultrasound for COVID-19

• • 

    

    Daniel Pryma, MD

    Peer

  4

  

  RestartResume

  Supplying Thyroid Cancer Treatment Through COVID-19

  Supplying Thyroid Cancer Treatment Through COVID-19

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Marcia Ryder, PhD MS RN

    Peer

  2

  

  RestartResume

  Midline Catheter Failures: Exploring the Role of Infusate Properties

  Midline Catheter Failures: Exploring the Role of Infusate Properties

• • 

    

    Ana Ferreira Castro, MD

    Peer

  • 

    

    Gilberto de Castro Junior, MD, PhD

    Peer

  • 

    

    Zujun Li, MD

    Peer

  • 

    

    Ricard Mesia, MD, PhD

    Peer

  5

  

  RestartResume

  Clinical Considerations in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

  Clinical Considerations in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

  0.25 credits

• 1
• 2
• 3
• …
• 7
• 8
• Next